Biogen CEO Chris Viehbacher and Travis Murdoch — fellow Canadians — hit it off when Biogen last year bought Murdoch's HI-Bio ...
With $185 million in series A funding and an army of experienced leaders in its ranks, Braveheart Bio is setting off to joust ...
Plus, TPG buys Hologic, UTSW researchers named to National Academy of Medicine, and Verily partners with NVIDIA.
The startup is advancing a drug licensed from China’s Hengrui Pharma that it claims could be “best-in-class” among a group of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback